4,0
23 mei 2026
Huidige werknemer, meer dan 10 jaar
Cambridge, MA
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Excellent company growth in the last five years. Pay equity. Engaging mission, science and motivated employees. Outstanding talents with rich expertise across R&D.
Minpunten
Bureaucracy slow down decision making. Conservative leadership in some disease areas impeding innovation due to risk avoidance. Wavering in decision making due to bias, presumptions or premature data.